Duthaler U

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.

15 papers · ORCID

ArticleLSD

Inter-individual variability in neural response to low doses of LSD.

Hutten NRPW, Quaedflieg CWEM, Mason NL +7

Europe PMC2024
ArticlePsilocybin

<i>In vitro</i> and <i>in vivo</i> metabolism of psilocybin's active metabolite psilocin.

Thomann J, Kolaczynska KE, Stoeckmann OV +7

Europe PMC2024
ArticleLSD

Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants.

Holze F, Erne L, Duthaler U +1

Europe PMC2024
ArticleMDMA

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Straumann I, Ley L, Holze F +7

Europe PMC2023
ArticlePsilocybin

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Ley L, Holze F, Arikci D +11

Europe PMC2023
ArticleDMT

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Vogt SB, Ley L, Erne L +12

Europe PMC2023
ArticleLSD

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.

Becker AM, Klaiber A, Holze F +5

Europe PMC2023
ArticlePsilocybin

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.

Holze F, Becker AM, Kolaczynska KE +2

Europe PMC2023
ArticleDMT

Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma.

Luethi D, Kolaczynska KE, Vogt SB +4

Europe PMC2022
ArticleMescaline

Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma.

Thomann J, Ley L, Klaiber A +2

Europe PMC2022
ArticlePsilocybin

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

Holze F, Ley L, Müller F +10

Europe PMC2022
ArticlePsilocybin

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

Becker AM, Holze F, Grandinetti T +8

Europe PMC2022
ArticlePsilocybin

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma.

Kolaczynska KE, Liechti ME, Duthaler U

Europe PMC2021
ArticleLSD

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Holze F, Liechti ME, Hutten NRPW +7

Europe PMC2021
ArticleLSD

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Holze F, Vizeli P, Ley L +8

Europe PMC2021